Sarcopenia and sarcopenic obesity

키워드

참고문헌 (63)

1. Janssen I, "Evolution of sarcopenia research", Appl Physiol Nutr Metab, 35, pp.707~712 (2010)
2. Newman AB, "Aging and Body Composition Study", J Am Geriatr Soc, 51, pp.323~330 (2003)
3. Janssen I, "The epidemiology of sarcopenia", Clin Geriatr Med, 27, pp.355~363 (2011)
4. Rosenberg IH, "Sarcopenia: origins and clinical relevance", J Nutr, 127(5 Suppl), pp.990S~991S (1997)
5. Lang T, "Sarcopenia: etiology, clinical consequences, intervention, and assessment", Osteoporos Int, 21, pp.543~559 (2010)
6. Cruz-Jentoft AJ, "Sarcopenia:European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
7. Edwards MH, "Novel approaches to the diagnosis of sarcopenia", J Clin Densitom, 18, pp.472~477 (2015)
8. Hun-Tae Kim, "An analysis of age-related loss of skeletal muscle mass and its significance on osteoarthritis in a Korean population", The Korean Journal of Internal Medicine, 31(3), pp.585~593 (2016), 대한내과학회
9. Wannamethee SG, "Muscle loss and obesity : the health implications of sarcopenia and sarcopenic obesity", Proc Nutr Soc, 74, pp.405~412 (2015)
10. Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147, pp.755~763 (1998)
11. Janssen I, "Low relative skeletal muscle mass(sarcopenia)in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50, pp.889~896 (2002)
12. Newman AB, "Sarcopenia: alternative definitions and associations with lower extremity function", J Am Geriatr Soc, 51, pp.1602~1609 (2003)
13. Kim TN, "Prevalence of sarcopenia and sarcopenic obesity in Korean adults : the Korean Sarcopenic Obesity Study", Int J Obes, 33, pp.885~892 (2009)
14. Studenski SA, "The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates", J Gerontol A Biol Sci Med Sci, 69, pp.547~558 (2014)
15. Cawthon PM, "Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness", J Gerontol A Biol Sci Med Sci, 69, pp.567~575 (2014)
16. 김경민, "Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia", The Korean Journal of Internal Medicine, 31(4), pp.643~650 (2016), 대한내과학회[DOI]
17. Al Snih S, "Hand grip strength and incident ADL disability in elderly Mexican Americans over a seven-year period", Aging Clin Exp Res, 16, pp.481~486 (2004)
18. Guralnik JM, "A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission", J Gerontol, 49, pp.M85~M94 (1994)
19. Guralnik JM, "Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery", J Gerontol A Biol Sci Med Sci, 55, pp.M221~M231 (2000)
20. Peel NM, "Gait speed as a measure in geriatric assessment in clinical settings: a systematic review", J Gerontol A Biol Sci Med Sci, 68, pp.39~46 (2013)
21. Abbatecola AM, "Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction", J Nutr Health Aging, 15, pp.890~895 (2011)
22. Bijlsma AY, "Diagnostic criteria for sarcopenia relate differently to insulin resistance", Age, 35, pp.2367~2375 (2013)
23. 최경묵, "Sarcopenia and Sarcopenic Obesity", Endocrinology and Metabolism, 28(2), pp.86~89 (2013), 대한내분비학회
24. Wang C, "Sarcopenia in the elderly: basic and clinical issues", Geriatr Gerontol Int, 12, pp.388~396 (2012)
25. Jensen GL, "Inflammation: roles in aging and sarcopenia", JPEN J Parenter Enteral Nutr, 32, pp.656~659 (2008)
26. Meng SJ, "Oxidative stress, molecular inflammation and sarcopenia", Int J Mol Sci, 11, pp.1509~1526 (2010)
27. Lang CH, "TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation", Am J Physiol Endocrinol Metab, 282, pp.E336~E347 (2002)
28. Schaap LA, "Inflammatory markers and loss of muscle mass (sarcopenia) and strength", Am J Med, 119, pp.526.e9~526.e17 (2006)
29. McPherron AC, "Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member", Nature, 387, pp.83~90 (1997)
30. Grobet L, "A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle", Nat Genet, 17, pp.71~74 (1997)
31. White TA, "Myostatin and sarcopenia: opportunities and challenges: a mini-review", Gerontology, 60, pp.289~293 (2014)
32. Srikanthan P, "Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III", PLoS One, 5, pp.e10805~ (2010)
33. Kim TN, "Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes:the Korean Sarcopenic Obesity Study (KSOS)", Diabetes Care, 33, pp.1497~1499 (2010)
34. 장학철, "Sarcopenia, Frailty, and Diabetes in Older Adults", Diabetes and Metabolism Journal, 40(3), pp.182~189 (2016), 대한당뇨병학회[DOI]
35. Hong HC, "Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study", Hepatology, 59, pp.1772~1778 (2014)
36. Han K, "Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010", PLoS One, 9, pp.e86902~ (2014)
37. Snijder MB, "Regional body composition as a determinant of arterial stiffness in the elderly: The Hoorn Study", J Hypertens, 22, pp.2339~2347 (2004)
38. Sanada K, "Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women", Eur J Clin Nutr, 66, pp.1093~1098 (2012)
39. Wijnhoven HA, "Region-specific fat mass and muscle mass and mortality in community-dwelling older men and women", Gerontology, 58, pp.32~40 (2012)
40. Han SS, "Lean mass index: a better predictor of mortality than body mass index in elderly Asians", J Am Geriatr Soc, 58, pp.312~317 (2010)
41. Wannamethee SG, "Decreased muscle mass and increased central adiposity are independently related to mortality in older men", Am J Clin Nutr, 86, pp.1339~1346 (2007)
42. Atkins JL, "Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men", J Am Geriatr Soc, 62, pp.253~260 (2014)
43. Hirani V, "Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the concord health and ageing in men project", J Am Med Dir Assoc, 16, pp.607~613 (2015)
44. Kim JH, "Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men", J Gerontol A Biol Sci Med Sci, 69, pp.1244~1252 (2014)
45. Filippin LI, "Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention", Aging Clin Exp Res, 27, pp.249~254 (2015)
46. Baumgartner RN, "Body composition in healthy aging", Ann N Y Acad Sci, 904, pp.437~448 (2000)
47. Lim KI, "The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS)", Clin Endocrinol, 73, pp.588~594 (2010)
48. Kim TN, "Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study", Clin Endocrinol, 78, pp.525~532 (2013)
49. Kim TN, "The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease", J Cell Biochem, 116, pp.1171~1178 (2015)
50. Zamboni M, "Sarcopenic obesity: a new category of obesity in the elderly", Nutr Metab Cardiovasc Dis, 18, pp.388~395 (2008)
51. Gregor MF, "Inflammatory mechanisms in obesity", Annu Rev Immunol, 29, pp.415~445 (2011)
52. Kim TN, "Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS)", PLoS One, 9, pp.e115407~ (2014)
53. Kohara K, "Sarcopenic obesity in aging population: current status and future directions for research", Endocrine, 45, pp.15~25 (2014)
54. Stenholm S, "Sarcopenic obesity: definition, cause and consequences", Curr Opin Clin Nutr Metab Care, 11, pp.693~700 (2008)
55. Lim S, "Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLo-SHA)", Diabetes Care, 33, pp.1652~1654 (2010)
56. Chung JY, "Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity", Arch Gerontol Geriatr, 56, pp.270~278 (2013)
57. Kim TN, "Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness", PLoS One, 9, pp.e100118~ (2014)
58. Lu CW, "Sarcopenic obesity is closely associated with metabolic syndrome", Obes Res Clin Pract, 7, pp.e301~e307 (2013)
59. Messier V, "Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study", Appl Physiol Nutr Metab, 34, pp.18~24 (2009)
60. dos Santos EP, "Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women", Arch Gerontol Geriatr, 59, pp.56~61 (2014)
61. Stephen WC, "Sarcopenic-obesity and cardiovascular disease risk in the elderly", J Nutr Health Aging, 13, pp.460~466 (2009)
62. Batsis JA, "Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III", Eur J Clin Nutr, 68, pp.1001~1007 (2014)
63. Tian S, "Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies", Geriatr Gerontol Int, 16, pp.155~166 (2016)

관련 논문AI추천